Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
株式のランク #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
株価
$0.2219522
最終同期: 2025-09-11
時価総額
$1.10B
変化(1日)
0.04%
変化(1年)
0.17%
CN
取引 Hubei Biocause Pharmaceutical Co., Ltd. (000627)

カテゴリー

Hubei Biocause Pharmaceutical Co., Ltd.(000627)の利益
Sep 2024 時点の利益 TTM: $-246.31M
Hubei Biocause Pharmaceutical Co., Ltd. の最新の財務報告によると、同社の現在の利益は $-246.31M です。2022 年には $32.59M の利益を上げ、これは 2021 年の利益 $53.98M と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Hubei Biocause Pharmaceutical Co., Ltd. の利益の推移(2000 〜 2026)
各年末の利益
利益 変化
2026 (TTM) $-246.31M -6.66%
2023 $-263.90M -909.84%
2022 $32.59M -39.64%
2021 $53.98M -75.67%
2020 $221.88M -57.48%
2019 $521.80M 36.14%
2018 $383.27M -8.47%
2017 $418.73M -15.31%
2016 $494.40M 859.98%
2015 $51.50M 192.79%
2014 $17.59M -182.99%
2013 $-21.20M -981.31%
2012 $2.40M -112.99%
2011 $-18.51M -493.30%
2010 $4.71M -45.74%
2009 $8.67M 709.23%
2008 $1.07M -93.04%
2007 $15.40M 107.42%
2006 $7.42M 610.69%
2005 $1.04M 72.62%
2004 $605.05K -110.58%
2003 $-5.72M -392.76%
2002 $1.95M -72.00%
2001 $6.97M 18.03%
2000 $5.91M 0.00%
同業他社の利益